Joint damage after transition to adult care for juvenile arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at how juvenile idiopathic arthritis (JIA), a type of childhood arthritis, affects joints like the hands, hips, and knees after a person moves from pediatric to adult care. It helps understand if joint damage worsens over time, which could guide future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with juvenile idiopathic arthritis (JIA) as a child (before age 16).
- You are between 16 and 25 years old.
- You started the move from pediatric to adult rheumatology care (after 2016).
- You have X-rays of your hands, hips, or knees showing that your growth plates are closed (meaning your bones have finished growing).
- You did not have another type of arthritis that started when you were an adult, and you don't have other bone or joint conditions that cause deformities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether children with early juvenile idiopathic arthritis do better by starting with one treatment approach and adjusting (stepping up or stepping down) based on how their arthritis responds. It may help find the safest, most effective long-term plan for controlling symptoms with fewer side effects.
This study looks at when it may be safe to stop or reduce arthritis medications in children whose juvenile idiopathic arthritis has been inactive for at least 6 months. The goal is to find the best time to stop treatment to avoid side effects while preventing flare-ups.
This study tests if removing certain foods can improve arthritis symptoms in children aged 6 to 17. It may be an option if current medicines are not working well or if you want to explore dietary changes.
This study looks at how to improve the shift from pediatric to adult rheumatology care for young people with chronic inflammatory rheumatic diseases. It aims to understand how healthcare services can better support this transition.
This trial tests whether children with juvenile idiopathic arthritis (JIA) who have been doing well for over a year can safely reduce their medications. The goal is to find the best way to keep arthritis under control while avoiding unnecessary treatments.
This study follows children and young adults newly diagnosed with certain types of arthritis or related conditions to learn more about their health over time. It may help doctors better understand how these diseases progress and how treatments work.
Hear when a new Juvenile Chronic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.